HighField Biopharmaceuticals
Shanghai, China· Est.
HighField Biopharmaceuticals focuses on developing innovative biologic therapies, particularly monoclonal antibodies, for the treatment of cancer and inflammatory diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
HighField Biopharmaceuticals focuses on developing innovative biologic therapies, particularly monoclonal antibodies, for the treatment of cancer and inflammatory diseases.
OncologyImmunologyBiologics